1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
66A0442B619FC08B2852584BE00709103
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/6A0442B619FC08B2852584BE00709103?OpenDocument
18
19OpenDocument
203.235.145.252
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Patient Focused Services » Patient Advocacy Groups

Document Excerpt: Patient Advocacy: Structure, Effectiveness and Relationship Management Outside the United States

DB Image

ID: MD-688


Features:

8 Info Graphics

20 Data Graphics

200 Metrics

3 Narratives


Pages/Slides: 4


Published: 2019


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".


To return to the study abstract to purchase the full study - click here

This excerpt includes research findings and metrics from document #5588 "Patient Advocacy: Structure, Effectiveness and Relationship Management Outside the United States".

Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Research; Clinical Research; Health Care; Communications; Medical; Biopharmaceutical; Laboratories


Companies Profiled:
AbbVie; Astellas; Bayer; BioMarin; Bluebird Bio; Covance; Bionical Emas; Lundbeck; Janssen; Merck; Merck Serono; NexGen Healthcare Communications; Novartis; Parkway Pantai; Sanofi; Servier; Shire; Spark Therapeutics; Takeda Pharmaceuticals; UCB Pharma; Tillotts Pharma; Teva Pharmaceutical Industries Ltd

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.